-
Private Equity’s Prominence in 2023 and 2024
by katehumphrey | Mar 19, 2024 8:56 am | Private Equity | 0 comments
Private equity (PE), for several years, has had a large presence in the healthcare M&A market. In 2023, there were 766 transactions that were completed by a private equity group, and/or a portfolio company. This equates to roughly 35% of the entire 2,197 healthcare acquisitions that were reported during 2023. This high percentage of PE... Read More » -
Broward Health Buys MOB in Coral Springs, Florida
by Avery Swett | Mar 18, 2024 3:22 pm | Medical Office Buildings, Other Services | 0 comments
Broward Health has purchased a Coral Springs, Florida medical office building (MOB) for $11 million. The property last traded ownership for $5.8 million in 2018, so it has nearly doubled in value, reflecting the strong demand for medical office space in Broward County. The property is a 40,926-square-foot MOB located north of Broward Health Coral... Read More » -
United Dental Corporation Expands Footprint in Tennessee
by Avery Swett | Mar 15, 2024 11:40 am | Physician Medical Groups | 0 comments
United Dental Corporation (UDC), a Miami, Florida-based dental services organization, announced that it has acquired Gorham and Ammarell Dentistry, marking its first acquisition in Tennessee. Gorham and Ammarell Dentistry is a general dentistry practice that has been operating in Nashville, Tennessee since 1969. According to its website, the... Read More » -
Children’s Autism Center Expands in Northeast Indiana With Child’s Play Plus
by Avery Swett | Mar 14, 2024 12:36 pm | Behavioral Health Care | 0 comments
The Children’s Autism Center announced that it has acquired local provider Child’s Play Plus, signaling a strategic move to enhance its services in Northeast Indiana. Starting in 2014 as one clinic specializing in autism services, Child’s Play Plus has become a multidisciplinary pediatric therapy center offering behavioral,... Read More » -
AstraZeneca Acquires Amolyt Pharma From Sofinnova Partners
by Avery Swett | Mar 14, 2024 12:35 pm | Biotechnology | 0 comments
Sofinnova Partners announced on March 14 that its portfolio company, Amolyt Pharma, has entered into a definitive agreement with AstraZeneca for its acquisition. The transaction includes $800 million upfront at deal closing, plus the right for Amolyt Pharma’s shareholders to receive an additional contingent payment of $250 million payable upon... Read More »
Categories
- Ambulatory Surgery Centers
- Behavioral Health Care
- Biotechnology
- CDMO
- CRO
- eHealth
- Healthcare M&A News Leads
- Healthcare Market Updates
- Healthcare Staffing
- Home Health & Hospice
- Hospitals
- Laboratories, MRI & Dialysis
- Long-Term Care
- Managed Care
- Medical Devices
- Medical Office Buildings
- Occupational Health
- Other Services
- Pharmaceuticals
- Physician Medical Groups
- Private Equity
- Rehabilitation
- SPAC
- Specialty Pharmacies
- Uncategorized
- Urgent Care Centers